Caris Life Sciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $216,833 | $181,398 | $120,915 | $100,049 |
Gross Profit | 147,506 | 113,685 | 57,063 | 37,554 |
EBITDA | 42,702 | -46,173 | -82,754 | -40,902 |
EBIT | 37,832 | -52,582 | -89,799 | -52,512 |
Net Income | 24,325 | -71,790 | -102,581 | -66,186 |
Net Change In Cash | 216,833 | 181,398 | 120,915 | 100,049 |
Free Cash Flow | 55,330 | 5,902 | -34,027 | -65,514 |
Cash | 753,221 | 718,934 | 31,201 | |
Basic Shares | 297,211 | 276,000 | 254,788 | 254,788 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $412,260 | $306,128 | $258,485 | $294,013 |
Gross Profit | 178,782 | 89,310 | 80,022 | 184,157 |
EBITDA | -182,952 | -260,804 | -245,894 | 254,457 |
EBIT | -231,865 | -309,805 | -294,147 | 143,807 |
Net Income | -281,890 | -341,415 | -320,827 | 27,733 |
Net Change In Cash | 412,260 | 306,128 | 258,485 | 294,013 |
Free Cash Flow | -253,643 | -298,419 | -327,961 | 57,566 |
Cash | 63,950 | 56,402 | 107,191 | 53,547 |
Basic Shares | 254,662 | 254,662 | 254,788 | 17,949 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0.08 |
2025-06-30 | -$1.11 |
2025-03-31 | -$0.35 |
